Addition of chromosome 17 polysomy and her2 amplification status improves the accuracy of clinicopathological factor-based progression risk stratification and tumor grading of non-muscle-invasive bladder cancer

HIGHLIGHTS

• who: Ildiku00f3 Kocsmu00e1r and colleagues from the Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, u00dcllou030bi Street, Venusberg-Campus , Building, Bonn, Germany have published the Article: Addition of Chromosome 17 Polysomy and HER2 Amplification Status Improves the Accuracy of Clinicopathological Factor-Based Progression Risk Stratification and Tumor Grading of Non-Muscle-Invasive Bladder Cancer, in the Journal: (JOURNAL)
• what: The authors aimed to predict the progression of NMIBCs to MIBC by assessing p53 expression polysomy of 17 (Chr17) and in the tissue specimens of the of 90 NMIBC patients. The authors aimed to investigate . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.